Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Impact of CRRT patterns on calcium levels in patients using citrate anticoagulants

Official title: Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions

Run by Fujian Provincial Hospital · NCT06021080 · Data updated 2026-11-12

This study is testing how different kidney treatment methods affect calcium levels in patients using a specific blood thinner called citrate.

More Renal Replacement Therapy trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment30 (estimated)
SponsorFujian Provincial Hospital
Academic / other
Locations1 site (Fuzhou, Fujian)
StatusRecruiting
StartedOctober 9, 2023
Main results expectedJune 9, 2026
Study endsDecember 9, 2026
Registry record updatedAugust 6, 2025
Trial IDNCT06021080 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are receiving citrate anticoagulation for renal replacement therapy.

Probably not a fit

Patients who are pregnant, have severe liver dysfunction, or are experiencing significant hypoxemia or inadequate tissue perfusion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study investigates how different continuous renal replacement therapy (CRRT) methods, specifically veno-venous hemofiltration (CVVH) and continuous veno-venous hemodialysis (CVVHD), affect ionized calcium concentrations in patients undergoing regional citrate anticoagulation. Patients will be randomly assigned to one of the two CRRT methods and will switch to the alternative method in subsequent sessions. Key measurements will include pre-filter and post-filter ionized calcium levels, as well as other electrolyte and citrate dose data collected throughout the treatment. The study aims to clarify the relationship between CRRT patterns and calcium levels, which is crucial for patient safety and treatment efficacy.

Why it matters

Potential benefit: If successful, this study could enhance the management of calcium levels in patients undergoing CRRT, potentially improving patient outcomes.

How similar studies have gone: While this approach is not widely tested, similar studies have explored the effects of anticoagulation methods on renal therapy outcomes, indicating potential for valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years old;
2. Receiving citrate anticoagulation;
3. Obtain Informed consent from patients or next of kin.

Exclusion Criteria:

1. Pregnant or lactating women;
2. Allergic to citrate anticoagulants;
3. Severe liver dysfunction (total bilirubin levels exceeding two times the normal range);
4. Hypoxemia (PaO2 \< 60 mmHg);
5. Inadequate tissue perfusion (blood pressure \< 90/60 mmHg despite high doses of vasoactive agents);
6. Hyperlactatemia (lactate\> 4 mmol/L);
7. Hypernatremia;
8. Estimated length of hospital stay \< 48h;
9. Participated in other studies.

Where it's running

  • Fujian Provincial Hospital
    Fuzhou, Fujian, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.